Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   A dual-luciferase bioluminescence system for the assessment of cellular therapies
  2. Torres Chavez, Alejandro G; McKenna, Mary K; Balasubramanian, Kishore; Riffle,Lisa; Patel,Nimit; Kalen,Joseph; St Croix,Brad; Leen, Ann M; Bajgain,Pradip
  3. Molecular Therapy. Oncology. 2024, Mar 21; 32(1): 200763.
  1. 2.   Coumarin luciferins and mutant luciferases for robust multi-component bioluminescence imaging
  2. Yao, Zi; Caldwell,Donald; Love, Anna C.; Kolbaba-Kartchner, Bethany; Mills, Jeremy H.; Schnermann,Martin; Prescher, Jennifer A.
  3. CHEMICAL SCIENCE. 2021, Aug 2;
  1. 3.   Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL(pro) Inhibitors
  2. Rawson, Jonathan M. O.; Duchon, Alice; Nikolaitchik, Olga A.; Pathak, Vinay K.; Hu, Wei-Shau
  3. Viruses. 2021, Jan 24; 13(2):
  1. 4.   Generation and validation of a highly sensitive bioluminescent HIV-1 reporter vector that simplifies measurement of virus release
  2. Kirui,James; Freed,Eric
  3. Retrovirology. 2020, May 19; 17(1): 12.
  1. 5.   HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles
  2. Liu, Yang; Nikolaitchik, Olga; Rahman, Sheikh; Chen, Jianbo; Pathak, Vinay; Hu, Wei-Shau
  3. Journal of molecular biology. 2017, Aug 04; 429(16): 2542-2555.
  1. 6.   Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin
  2. Day, C. P.; Carter, J.; Bonomi, C.; Hollingshead, M.; Merlino, G.
  3. International Journal of Cancer. 2012, Jan; 130(1): 190-199.
  1. 7.   Effect of North Bicyclo[3.1.0]hexane 2 '-Deoxy-pseudosugars on RNA Interference: A Novel Class of siRNA Modification
  2. Terrazas, M.; Ocampo, S. M.; Perales, J. C.; Marquez, V. E.; Eritja, R.
  3. Chembiochem. 2011, May; 12(7): 1056-1065.
  1. 8.   Bioluminescent imaging study FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models
  2. Sun, H. H.; Pisle, S.; Gardner, E. R.; Figg, W. D.
  3. Cancer Biology & Therapy. 2010, Jul; 10(1): 38-43.
  1. 9.   Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes
  2. Li, H.; Wright, P. W.; Anderson, S. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 612: 377-91.
  1. 10.   Four-Antigen Mixture Containing V-Cyclin for Serological Screening of Human Herpesvirus 8 Infection
  2. Burbelo, P. D.; Leahy, H. P.; Groot, S.; Bishop, L. R.; Miley, W.; Iadarola, M. J.; Whitby, D.; Kovacs, J. A.
  3. Clinical and Vaccine Immunology. 2009 16(5): 621-627.
  1. 11.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 12.   Epstein-Barr virus-encoded latent membrane protein 1 modulates cyclin D1 by c-Jun/Jun B heterodimers
  2. Song, X.; Tao, Y. G.; Zeng, L.; Yang, J.; Tang, F. Q.; Lee, L. M.; Gong, J. P.; Wu, Q.; Cao, Y.
  3. Science in China Series C-Life Sciences. 2005, AUG; 48(4): 385-393.
  1. 13.   Repression of the inhibin alpha-subunit gene by the transcription factor CCAAT/enhancer-binding protein-beta
  2. Burkart, A. D.; Mukherjee, A.; Sterneck, E.; Johnson, P. F.; Mayo, K. E.
  3. Endocrinology. 2005, APR; 146(4): 1909-1921.
  1. 14.   Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter
  2. Kuzmin, I.; Geil, L.; Gibson, L.; Cavinato, T.; Loukinov, D.; Lobanenkov, V.; Lerman, M. I.
  3. Journal of Molecular Biology. 2005, FEB 18; 346(2): 411-422.
  1. 15.   Co-operative functions between nuclear factors NF kappa B and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells
  2. Xiao, W. H.; Hodge, D. R.; Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Prostate. 2004, DEC 1; 61(4): 354-370.
  1. 16.   A potential role for imaging technology in anticancer efficacy evaluations
  2. Hollingshead, M. G.; Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Shoemaker, R.; Melillo, G.; Sausville, E. A.
  3. European Journal of Cancer. 2004 40(6): 890-898.
  1. 17.   Polyoma enhancer activator 3, an Ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells
  2. Liu, Y. M.; Borchert, G. L.; Phang, J. M.
  3. Journal of Biological Chemistry. 2004 279(18): 18694-18700.
  1. 18.   The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. MacDonald, C. J.; Ciolino, H. P.; Yeh, G. C.
  3. Cancer Research. 2004 64(1): 429-434.
  1. 19.   Multi-fold improvements in tumor cell detection and drug screening sensitivity using luciferase based technology
  2. Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Melillo, G.; Scudiero, D. A.; Shoemaker, R. H.; Sausville, E. A.; Hollingshead, M. G.
  3. Clinical Cancer Research. 2003 9(16): 6217S-6217S.
  1. 20.   Transcriptional activation analysis using bioluminescent reporter assays
  2. Hodge, D. R.; Clausen, P. A.
  3. Molecular Biotechnology. 2000 16(1): 67-76.
  1. 21.   Long-Term Monitoring of Circadian Rhythms in C-Fos Gene Expression From Suprachiasmatic Nucleus Cultures
  2. Geusz, M. E.; Fletcher, C.; Block, G. D.; Straume, M.; Copeland, N. G.; Jenkins, N. A.; Kay, S. A.; Day, R. N.
  3. Current Biology. 1997 7(10): 758-766.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel